Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$661K Buy
10,508
+233
+2% +$16.3K ﹤0.01% 1670
2026
Q1
$775K Sell
10,275
-822
-7% -$58.6K ﹤0.01% 1443
2025
Q4
$685K Buy
11,097
+1,290
+13% +$75.9K ﹤0.01% 1446
2025
Q3
$574K Buy
9,807
+603
+7% +$35.1K ﹤0.01% 1372
2025
Q2
$540K Buy
9,204
+2,636
+40% +$149K ﹤0.01% 1315
2025
Q1
$329K Buy
6,568
+951
+17% +$48.7K ﹤0.01% 1358
2024
Q4
$263K Buy
+5,617
New +$267K ﹤0.01% 1404

Other funds holding NTR

&Partners's NTR Position: Q2 2026 in Review

&Partners increased its Nutrien (NTR) stake by 2.3% in Q2 2026, buying an estimated $16.3K and bringing the position to 10,508 shares worth $661K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

&Partners first reported a position in NTR in Q4 2024 and has held it in 7 quarters since. The position peaked at $775K in Q1 2026. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • &Partners held 10,508 shares of Nutrien worth $661K as of Q2 2026.
  • &Partners bought 233 Nutrien shares in Q2 2026, an estimated $16.3K.
  • Nutrien made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1670 holding.
  • &Partners first reported a position in Nutrien in Q4 2024 and has held it in 7 quarters since.
  • &Partners's Nutrien position peaked at $775K in Q1 2026.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.